Indication
Open-Angle Glaucoma
4 clinical trials
9 products
Clinical trial
A Phase III, Randomized, Observer-Masked, Active-Controlled, Parallel-Group, Multinational and Multicenter Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution 0.002% Compared With Latanoprost Ophthalmic Solution 0.005% in Subjects With Open-Angle Glaucoma or Ocular Hypertension- PEONY StudyStatus: Completed, Estimated PCD: 2019-01-01
Product
LatanoprostProduct
DE-117Product
OPC-1085ELClinical trial
A Phase III, Multi-center, Randomized, Single-blind (to Evaluator), Parallel, and Positive-controlled Clinical Trial Evaluating the Efficacy and Safety of OPC-1085EL Ophthalmic Solution in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese SubjectsStatus: Recruiting, Estimated PCD: 2024-03-30
Clinical trial
A Randomized, Single Center, Masked, Crossover Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity in Patients With Ocular Hypertension or Primary Open Angle GlaucomaStatus: Completed, Estimated PCD: 2021-05-20
Product
Latanoprostene BunodProduct
Timolol maleateClinical trial
A Phase III, Multinational, Multicenter, Investigator-Masked, Randomized, Active Controlled Trial, Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension Over a 3-Month Period, Followed by a 12-Month Follow-Up With Open-Label DE-130A Treatment.Status: Completed, Estimated PCD: 2022-02-03
Product
DE-130AProduct
Xalatan®Product
DE-130A/DE-130AProduct
Xalatan®/DE-130A